Net income increased 257.5%
Net income changed +257.5% from the comparable as-filed period.
-$1.2M→$2.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →OESX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure decreased 89.1%
Capital expenditure changed -89.1% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
$55,000→$6,0006 prior comparisons
Cash & equivalents increased 44.9%
Cash & equivalents changed +44.9% from the comparable as-filed period.
$3.6M→$5.2M3 prior comparisons
Debt decreased 23.1%
Debt changed -23.1% from the comparable as-filed period.
$8.5M→$6.5M3 prior comparisons
Free-cash-flow proxy increased 336.1%
Free-cash-flow proxy changed +336.1% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
-$570,000→$1.3M6 prior comparisons
Gross margin moved 447 bp higher
Gross margin changed +447 basis points from the comparable as-filed period.
30.15%→34.62%3 prior comparisons
Gross profit increased 51.0%
Gross profit changed +51.0% from the comparable as-filed period.
$5.9M→$8.9M3 prior comparisons
Operating cash flow increased 362.5%
Operating cash flow changed +362.5% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
-$515,000→$1.4M6 prior comparisons
Operating income increased 308.4%
Operating income changed +308.4% from the comparable as-filed period.
-$1.0M→$2.1M3 prior comparisons
Operating margin moved 1338 bp higher
Operating margin changed +1338 basis points from the comparable as-filed period.
-5.17%→8.20%3 prior comparisons
Research & development increased 28.8%
Research & development changed +28.8% from the comparable as-filed period.
$208,000→$268,0003 prior comparisons
Revenue increased 31.5%
Revenue changed +31.5% from the comparable as-filed period.
$19.6M→$25.7M3 prior comparisons
Capex / revenue moved 26 bp lower
Capex / revenue changed -26 basis points from the comparable as-filed period.
0.28%→0.02%2 prior comparisons
Inventory increased 0.7%
Inventory changed +0.7% from the comparable as-filed period.
$10.3M→$10.4M3 prior comparisons
Stock-based compensation decreased 4.2%
Stock-based compensation changed -4.2% from the comparable as-filed period.
$166,000→$159,0003 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.